स्तन कैंसर के विभिन्न प्रकार: विशेष उपप्रकारों को समझना

For UPSC Prelims, remember that breast cancer is not a single disease but a family of diseases. Invasive lobular carcinoma (ILC) is the second most common type. Also, know that some subtypes like tubular, colloid, and adenoid cystic carcinomas are less aggressive, while micropapillary and metaplastic carcinomas are more aggressive.

Invasive lobular carcinoma (ILC) is the second most common type of invasive breast cancer. Unlike the more common invasive ductal carcinoma, ILC may not present as a distinct lump, making it harder to detect on mammograms. This difference in presentation is a key characteristic.

Understanding breast cancer subtypes is crucial for personalized medicine because different subtypes respond differently to treatment. Genomic testing, like gene expression profiling, helps assess recurrence risk and guide chemotherapy decisions, tailoring treatment to individual cancer characteristics for maximum effectiveness and minimal side effects.

Recent developments emphasize personalized medicine, using genomic testing like gene expression profiling to assess recurrence risk and guide chemotherapy decisions. This aims to tailor treatment to individual cancer characteristics, maximizing effectiveness and minimizing side effects.

Understanding that breast cancer has different subtypes emphasizes the importance of early and accurate diagnosis. Knowing that some subtypes are harder to detect (like ILC) or more aggressive can encourage individuals to seek prompt medical evaluation for any breast changes, leading to timely treatment and potentially better outcomes.

Early evaluation, including imaging and biopsy, is crucial because breast cancer is not a single disease. Different subtypes require tailored treatment approaches. Imaging and biopsy help in accurate diagnosis and timely treatment, which are essential for improving patient outcomes, especially for aggressive subtypes.